The control group (C) received 2 L/min O2 in 18 min/day for seven days; the first study group (S1) received 1 minimum alveolar concentration
sevoflurane + 2 L/min O2 in 18 min/day for seven days; the second group (S2) received 1 minimum alveolar concentration
sevoflurane + 2 L/min O2 in 18 min/day for seven days and no treatment for the following seven days; the third group (S3) received 1 minimum alveolar concentration
sevoflurane + 2 L/min O2 in 18 min/day for 14 days; the fourth group (S4) received 1 minimum alveolar concentration
sevoflurane + 2 L/min O2 in 18 min/day for 14 days and no treatment for the following seven days; and the fifth group (S5) received 1 minimum alveolar concentration
sevoflurane + 2 L/min O2 in 18 min/day for 14 days and no treatment for the following 14 days.
It was reported that
sevoflurane postconditioning reduced endotoxin (lipopolysaccharide, LPS)-induced ALI, protecting lung function (12).
Sevoflurane, a new inhalation anesthetic agent, is pleasant smelling, non-irritating to the airway, has a low blood gas solubility coefficient, good muscle relaxant effect, and high inspired concentration can be given without side effects or discomfort.
KEYWORDS: Propofol,
Sevoflurane, Cardiopulmonary bypass, Cardiac surgery.
By using rocuronium and its reversal agents sugammadex, lidocaine, [sz]-2 agonist, epinephrine,
sevoflurane, hydrocortisone, magnesium sulfate, and deep extubation, we were able to intubate smoothly and extubate successfully after the surgery without intensive care.
Historically they, and the wider NHS, have used desflurane, an agent 60 times more polluting per hour of anaesthesia then a similar gas,
sevoflurane.
The protective effect of
sevoflurane on cardiac and cerebral ischemia has been established.
After preoxy-genation, inhalation induction was performed with 8%
sevoflurane in oxygen.
[5, 6]
Sevoflurane is a recently introduced halogenated volatile anaesthetic agent.